Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W David Gryska


  • Director at Seattle Genetics Inc (SGEN), 2020-05-19
  • Director at Pdl Biopharma Inc. (PDLI), 2019-06-25
  • Director at Aerie Pharmaceuticals Inc (AERI), 2019-05-23
  • Executive Vice President, Cfo at Incyte Corp (INCY), 2018-07-18
  • Director at Argos Therapeutics Inc (ARGS), 2014-02-07
  • Director at Hyperion Therapeutics Inc (HPTX), 2013-05-01
  • Chief Operating Officer at Myrexis Inc. (MYRX), 2012-05-21
  • Chief Financial Officer at Celgene Corp (CELG), 2010-07-15
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGEN $84.85 2,500 Director 48,013 2019-10-01 Filing
SGEN $85.33 2,500 Director 48,013 2019-10-01 Filing
SGEN $74.01 206 Director 45,050 2019-04-01 Filing
SGEN $73.38 4,794 Director 45,256 2019-04-01 Filing
SGEN $65.04 5,000 Director 45,050 2019-01-08 Filing